Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility

被引:176
作者
Handschuh, G
Candidus, S
Luber, B
Reich, U
Schott, C
Oswald, S
Becke, H
Hutzler, P
Birchmeier, W
Höfler, H
Becker, KF
机构
[1] GSF Forschungszentrum Umwelt & Gesundheit, Inst Pathol, D-85764 Neuherberg, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, D-81675 Munich, Germany
[3] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
关键词
E-cadherin; gastric carcinoma; cell adhesion; motility; morphology;
D O I
10.1038/sj.onc.1202790
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A major function of the cell-to-cell adhesion molecule E-cadherin is the maintenance of cell adhesion and tissue integrity. E-cadherin deficiency in rumours leads to changes in cell morphology and motility, so that E-cadherin is considered to be a suppressor of invasion. In this study we investigated the functional consequences of three tumour-associated gene mutations that affect the extracellular portion of E-cadherin: in-frame deletions of exons 8 or 9 and a point mutation in exon 8, as they were found in human gastric carcinomas. Human MDA-MB-435S breast carcinoma cells and mouse L fibroblasts were stably transfected with the wild-type and mutant cDNAs, and the resulting changes in localization of E-cadherin, cell morphology, strength of calcium-dependent aggregation as well as cell motility and actin cytoskeleton organization were studied. We found that cells transfected with wild-ty pe E-cadherin showed an epitheloid morphology, while all cell lines expressing mutant E-cadherin exhibited more irregular cell shapes. Cells expressing E-cadherin mutated in exon 8 showed the most scattered appearance, whereas cells with deletion of exon 9 had an intermediate state, Mutant E-cadherins were localized to the lateral regions of cell-to-cell contact sites. Additionally, both exon 8-mutated E-cadherins showed apical and perinuclear localization, and actin filaments were drastically reduced. MDA-MB-435S cells with initial calcium-dependent cell aggregation exhibited decreased aggregation and, remarkably, increased cell motility, when mutant E-cadherin was expressed. Therefore, we conclude that these E-cadherin mutations may not simply affect cell adhesion but may act in a trans-dominant-active manner, i.e. lead to increased cell motility. Our study suggests that E-cadherin mutations affecting exons 8 or 9 are the cause of multiple morphological and functional disorders and could induce the scattered morphology and the invasive behaviour of diffuse type-gastric carcinomas.
引用
收藏
页码:4301 / 4312
页数:12
相关论文
共 86 条
[1]   Lateral self-assembly of E-cadherin directed by cooperative calcium binding [J].
Alattia, JR ;
Ames, JB ;
Porumb, T ;
Tong, KI ;
Heng, YM ;
Ottensmeyer, P ;
Kay, CM ;
Ikura, M .
FEBS LETTERS, 1997, 417 (03) :405-408
[2]   ENDOCAM - A NOVEL ENDOTHELIAL-CELL CELL-ADHESION MOLECULE [J].
ALBELDA, SM ;
OLIVER, PD ;
ROMER, LH ;
BUCK, CA .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1227-1237
[3]  
Bailey T, 1998, AM J PATHOL, V152, P135
[4]   EXON SKIPPING IN THE E-CADHERIN GENE TRANSCRIPT IN METASTATIC HUMAN GASTRIC CARCINOMAS [J].
BECKER, KF ;
ATKINSON, MJ ;
REICH, U ;
HUANG, HH ;
NEKARDA, H ;
SIEWERT, JR ;
HOFLER, H .
HUMAN MOLECULAR GENETICS, 1993, 2 (06) :803-804
[5]  
BECKER KF, 1994, CANCER RES, V54, P3845
[6]   Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β [J].
Behrens, J ;
Jerchow, BA ;
Würtele, M ;
Grimm, J ;
Asbrand, C ;
Wirtz, R ;
Kühl, M ;
Wedlich, D ;
Birchmeier, W .
SCIENCE, 1998, 280 (5363) :596-599
[7]  
BEHRENS J, 1991, EXP SUPPL, V59, P109
[8]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[9]   CLONING AND CHARACTERIZATION OF THE HUMAN INVASION SUPPRESSOR GENE E-CADHERIN (CDH1) [J].
BERX, G ;
STAES, K ;
VANHENGEL, J ;
MOLEMANS, F ;
BUSSEMAKERS, MJG ;
VANBOKHOVEN, A ;
VANROY, F .
GENOMICS, 1995, 26 (02) :281-289
[10]  
Berx G, 1996, ONCOGENE, V13, P1919